Dr. Noor Tariq Naeem holds a PhD in Genetic Engineering and Biotechnology. His research primarily focuses on leukemia, immunology, and molecular biology. He has published several research articles in reputed journals, including studies on the immunological and molecular investigation of Epstein-Barr Virus (EBV) in Iraqi patients with chronic lymphocytic leukemia. Additionally, his work covers topics such as beta endorphin levels in acute myeloid leukemia patients, histopathology of the liver under Temozolomide drug, and gene expression of hypoxia-inducible factor-1a in chronic myeloid leukemia.